Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stearns

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1979
The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNUV A Levin, J Stearns, A Byrd, et al.
Thrombosis and Haemostasis|April 12, 1990
Characterization of a mode of specific binding of fibrin monomer through its amino-terminal domain by macrophages and macrophage cell-linesJ R Shainoff, D J Stearns, P M DiBello, et al.
Toxins|December 4, 2012
Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animalsChad L Mayer, Caitlin S Leibowitz, Shinichiro Kurosawa, et al.
The American Journal of Pathology|August 1, 2006
Sepsis and pathophysiology of anthrax in a nonhuman primate modelDeborah J Stearns-Kurosawa, Florea Lupu, Fletcher B Taylor, et al.
Infection and Immunity|March 24, 2010
Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coliD J Stearns-Kurosawa, Valta Collins, Scott Freeman, et al.
Neuromodulation : Journal of the International Neuromodulation Society|January 28, 2016
Health Services Utilization and Payments in Patients With Cancer Pain: A Comparison of Intrathecal Drug Delivery vs. Conventional Medical ManagementLisa J Stearns, Jennifer A Hinnenthal, Krisstin Hammond, et al.
Annual Review of Pathology|October 5, 2010
The pathogenesis of sepsisDeborah J Stearns-Kurosawa, Marcin F Osuchowski, Catherine Valentine, et al.
Obstetrics and Gynecology|May 1, 1974
Evaluation of a latex agglutination-inhibition slide pregnancy test (Pregnosis)C A Horwitz, E Jerome, C Paulson, et al.
The Journal of Biological Chemistry|January 15, 1988
The interaction of a Ca2+-dependent monoclonal antibody with the protein C activation peptide region. Evidence for obligatory Ca2+ binding to both antigen and antibodyD J Stearns, S Kurosawa, P J Sims, et al.
Lab on a Chip|February 2, 2018
Microfluidic detection of movements of Escherichia coli for rapid antibiotic susceptibility testingVural Kara, Chuanhua Duan, Kalpana Gupta, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1979
The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNUV A Levin, J Stearns, A Byrd, et al.
Thrombosis and Haemostasis|April 12, 1990
Characterization of a mode of specific binding of fibrin monomer through its amino-terminal domain by macrophages and macrophage cell-linesJ R Shainoff, D J Stearns, P M DiBello, et al.
Toxins|December 4, 2012
Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animalsChad L Mayer, Caitlin S Leibowitz, Shinichiro Kurosawa, et al.
The American Journal of Pathology|August 1, 2006
Sepsis and pathophysiology of anthrax in a nonhuman primate modelDeborah J Stearns-Kurosawa, Florea Lupu, Fletcher B Taylor, et al.
Infection and Immunity|March 24, 2010
Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coliD J Stearns-Kurosawa, Valta Collins, Scott Freeman, et al.
Neuromodulation : Journal of the International Neuromodulation Society|January 28, 2016
Health Services Utilization and Payments in Patients With Cancer Pain: A Comparison of Intrathecal Drug Delivery vs. Conventional Medical ManagementLisa J Stearns, Jennifer A Hinnenthal, Krisstin Hammond, et al.
Annual Review of Pathology|October 5, 2010
The pathogenesis of sepsisDeborah J Stearns-Kurosawa, Marcin F Osuchowski, Catherine Valentine, et al.
Obstetrics and Gynecology|May 1, 1974
Evaluation of a latex agglutination-inhibition slide pregnancy test (Pregnosis)C A Horwitz, E Jerome, C Paulson, et al.
The Journal of Biological Chemistry|January 15, 1988
The interaction of a Ca2+-dependent monoclonal antibody with the protein C activation peptide region. Evidence for obligatory Ca2+ binding to both antigen and antibodyD J Stearns, S Kurosawa, P J Sims, et al.
Lab on a Chip|February 2, 2018
Microfluidic detection of movements of Escherichia coli for rapid antibiotic susceptibility testingVural Kara, Chuanhua Duan, Kalpana Gupta, et al.
Pageof 7